SB 971
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
SB 971
Bleeding disorders: blood clotting products
California · Vetoed
Lobbied on it8 of 12
Hemophilia Council of California4 reportsHerndon Healthcare, Inc. dba Herndon Pharmacy3 reportsPlasma Protein Therapeutics Association3 reportsCalifornia Society of Health-System Pharmacists2 reportsTalecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc.2 reportsBaxter Healthcare Corporation1 reportBD1 reportCSL Behring1 reportEvery link on this map
The same connections as a table, with the reason each one is here.
| Fran Pavley | Sponsors | Fran Pavley sponsored SB 971. | None |
| Hemophilia Council of California | Lobbied on it | Hemophilia Council of California named SB 971 in 4 lobbying reports. | 4 reports |
| Herndon Healthcare, Inc. dba Herndon Pharmacy | Lobbied on it | Herndon Healthcare, Inc. dba Herndon Pharmacy named SB 971 in 3 lobbying reports. | 3 reports |
| Plasma Protein Therapeutics Association | Lobbied on it | Plasma Protein Therapeutics Association named SB 971 in 3 lobbying reports. | 3 reports |
| California Society of Health-System Pharmacists | Lobbied on it | California Society of Health-System Pharmacists named SB 971 in 2 lobbying reports. | 2 reports |
| Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc. | Lobbied on it | Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc. named SB 971 in 2 lobbying reports. | 2 reports |
| Baxter Healthcare Corporation | Lobbied on it | Baxter Healthcare Corporation named SB 971 in 1 lobbying report. | 1 report |
| BD | Lobbied on it | BD named SB 971 in 1 lobbying report. | 1 report |
| CSL Behring | Lobbied on it | CSL Behring named SB 971 in 1 lobbying report. | 1 report |